| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 5392-5399, Copyright © 1996 by Endocrine Society
ARTICLES |
MA Zeiger, M Saji, P Caturegli, WH Westra, LD Kohn and MA Levine
Department of Surgery, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA.
Activating mutations of the alpha subunit of the G protein G(s) (G(s)alpha) have been identified in thyroid adenomas and well- differentiated thyroid carcinomas. To examine the role of activating mutations of G(s)alpha in thyroid neoplasia, we transfected rat follicular thyroid (FRTL-5) cells with a transgene in which the cholera toxin A1 subunit (CTA1) is expressed under the control of the rat thyroglobulin gene promoter (TG). This transgene recapitulates effects of the activating mutation of G(s)alpha by its ability to ADP- ribosylate and thereby inhibit GTPase activity of endogenous G(s)alpha molecules. To assess the effect of G(s)alpha activation on cell growth, TGCTA1, or control, pM AM neotransfected FRTL-5 cells (10(4)-10(6)) were injected s.c. into nude mice. TGCTA1-transfected FRTL-5 cells grow in nude mice, whereas control cells do not. Tumor histology revealed increased mitotic activity, infiltration of skeletal muscle, perineural invasion, and plugging of lymphatic spaces. In addition, nude mice injected with TGCTA1 transfected cells or xenografted with the tumors developed metastases to lung. These results indicate that activation of G(s)alpha and constitutive production of cAMP in FRTL-5 cells can result in TSH-independent cellular proliferation and neoplastic transformation.
This article has been cited by other articles:
![]() |
G. P. Prevost, M. O. Lonchampt, S. Holbeck, S. Attoub, D. Zaharevitz, M. Alley, J. Wright, M. C. Brezak, H. Coulomb, A. Savola, et al. Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric G{alpha}/G{beta}{gamma} Protein Complex. Cancer Res., September 15, 2006; 66(18): 9227 - 9234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramalingam, S. Rafii, S. Worgall, N. R. Hackett, and R. G. Crystal Induction of Endogenous Genes following Infection of Human Endothelial Cells with an E1- E4+ Adenovirus Gene Transfer Vector J. Virol., December 1, 1999; 73(12): 10183 - 10190. [Abstract] [Full Text] |
||||
![]() |
M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text] |
||||
![]() |
M. A. Zeiger, M. Saji, Y. Gusev, W. H. Westra, Y. Takiyama, W. C. Dooley, L. D. Kohn, and M. A. Levine Thyroid-Specific Expression of Cholera Toxin A1 Subunit Causes Thyroid Hyperplasia and Hyperthyroidism in Transgenic Mice Endocrinology, August 1, 1997; 138(8): 3133 - 3140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |